SS-31 (elamipretide) , a mitochondria-targeted peptide that stabilizes cardiolipin to support energy production, became the first FDA-approved mitochondrial therapeutic in 2025, though only for the rare Barth syndrome, with the brain rationale still mechanistic and no cognitive trials
This level of meticulous planning is a hallmark of high-quality peptide research
An IV drip includes fluid and takes longer
In an interview, Lurie said allowing peptides on the market without clinical testing poses a profound threat to FDA's decades-old system for vetting drugs
See Nuri Clinic Peptide Programs Licensed US providers affiliate link We offer GHK-Cu as part of a broader, research-driven approach to peptide support, one that prioritizes function, healing, and overall health
Its essential for red blood cell production, DNA synthesis, energy metabolism, and neurological function